Overall, moderate-to-strong FAM159B expression (average IRS > 5) was seen in pituitary adenomas, medullary and anaplastic thyroid carcinomas, parathyroid adenomas, adenocarcinomas of the lung, SCLCs, ovarian carcinomas and lymphomas. This evidence concerns the gene SHISAL2B and pituitary gland adenoma.